Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Grottoli

Showing results (61-70 of 124) with videos related to

Pageof 13
Sort By:
Journal of Endocrinological Investigation|April 9, 1999
Three-month treatment with metformin or dexfenfluramine does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in abdominal obesityS E Oleandri, M Maccario, R Rossetto, et al.
Clinical Endocrinology|September 5, 2001
Elderly subjects show severe impairment of dehydroepiandrosterone sulphate and reduced sensitivity of cortisol and aldosterone response to the stimulatory effect of ACTH(1-24)R Giordano, L Di Vito, F Lanfranco, et al.
The Journal of Clinical Endocrinology and Metabolism|February 2, 2006
Cortistatin-17 and somatostatin-14 display the same effects on growth hormone, prolactin, and insulin secretion in patients with acromegaly or prolactinomaS Grottoli, V Gasco, F Broglio, et al.
The Journal of Clinical Endocrinology and Metabolism|November 4, 2000
Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humansL Gianotti, M Maccario, F Lanfranco, et al.
European Journal of Endocrinology|October 1, 1996
Short-term administration of intranasal or oral Hexarelin, a synthetic hexapeptide, does not desensitize the growth hormone responsiveness in human agingE Ghigo, E Arvat, L Gianotti, et al.
Dementia (Basel, Switzerland)|September 1, 1996
The enhancing effect of pyridostigmine on the GH response to GHRH undergoes an accelerated age-related reduction in Down syndromeE Arvat, L Gianotti, L Ragusa, et al.
Pituitary|November 9, 2020
Biliary adverse events in acromegaly during somatostatin receptor ligands: predictors of onset and response to ursodeoxycholic acid treatmentN Prencipe, C Bona, D Cuboni, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|July 31, 2001
Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiencyM Maccario, G Aimaretti, S Grottoli, et al.
Journal of Endocrinological Investigation|June 7, 2011
Effects of chronic slow release-lanreotide treatment on insulin-like growth factor system and metabolic parameters in acromegalic patientsV Gasco, G Beccuti, F Marotta, et al.
Journal of Endocrinological Investigation|July 29, 2004
The adrenal sensitivity to ACTH stimulation is preserved in anorexia nervosaF Lanfranco, L Gianotti, A Picu, et al.
Pageof 13

Showing results (61-70 of 124) with videos related to

Sort By:
Pageof 13
Journal of Endocrinological Investigation|April 9, 1999
Three-month treatment with metformin or dexfenfluramine does not modify the effects of diet on anthropometric and endocrine-metabolic parameters in abdominal obesityS E Oleandri, M Maccario, R Rossetto, et al.
Clinical Endocrinology|September 5, 2001
Elderly subjects show severe impairment of dehydroepiandrosterone sulphate and reduced sensitivity of cortisol and aldosterone response to the stimulatory effect of ACTH(1-24)R Giordano, L Di Vito, F Lanfranco, et al.
The Journal of Clinical Endocrinology and Metabolism|February 2, 2006
Cortistatin-17 and somatostatin-14 display the same effects on growth hormone, prolactin, and insulin secretion in patients with acromegaly or prolactinomaS Grottoli, V Gasco, F Broglio, et al.
The Journal of Clinical Endocrinology and Metabolism|November 4, 2000
Arginine counteracts the inhibitory effect of recombinant human insulin-like growth factor I on the somatotroph responsiveness to growth hormone-releasing hormone in humansL Gianotti, M Maccario, F Lanfranco, et al.
European Journal of Endocrinology|October 1, 1996
Short-term administration of intranasal or oral Hexarelin, a synthetic hexapeptide, does not desensitize the growth hormone responsiveness in human agingE Ghigo, E Arvat, L Gianotti, et al.
Dementia (Basel, Switzerland)|September 1, 1996
The enhancing effect of pyridostigmine on the GH response to GHRH undergoes an accelerated age-related reduction in Down syndromeE Arvat, L Gianotti, L Ragusa, et al.
Pituitary|November 9, 2020
Biliary adverse events in acromegaly during somatostatin receptor ligands: predictors of onset and response to ursodeoxycholic acid treatmentN Prencipe, C Bona, D Cuboni, et al.
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|July 31, 2001
Effects of 36 hour fasting on GH/IGF-I axis and metabolic parameters in patients with simple obesity. Comparison with normal subjects and hypopituitary patients with severe GH deficiencyM Maccario, G Aimaretti, S Grottoli, et al.
Journal of Endocrinological Investigation|June 7, 2011
Effects of chronic slow release-lanreotide treatment on insulin-like growth factor system and metabolic parameters in acromegalic patientsV Gasco, G Beccuti, F Marotta, et al.
Journal of Endocrinological Investigation|July 29, 2004
The adrenal sensitivity to ACTH stimulation is preserved in anorexia nervosaF Lanfranco, L Gianotti, A Picu, et al.
Pageof 13